March 14, 2016 by David Pinto and Chain Drug Review
CVS Health, David Pinto, Fast Company, Larry Merlo
2016, Issue 03-14-2016, Issues, Opinion
Fast Company, one of the more appealing and relevant business publications to have come along in recent years, recently compiled a list of the world’s 50 most innovative companies. Several familiar names were included, perhaps most notably to retail students, CVS Health. Not surprisingly, Fast Company presented a strong case for CVS’ inclusion, but it
February 22, 2016 by Geoff Walden and Chain Drug Review
Brian Cornell, CVS Health, Helena Foulkes, John Mulligan, Larry Merlo, Target Corp.
2016, Issue 02-22-2016, Issues, News
WESLEY CHAPEL, N.C. — CVS Health has debuted its first rebranded pharmacies inside Target Corp. stores. The pharmacies, in six stores in North Carolina, are being operated through a store-within-a-store format under the CVS/pharmacy banner. CVS, which completed its $1.9 billion purchase of Target’s 1,672 pharmacies and 79 clinics in December, will rebrand the prescription
February 9, 2016 by Chain Drug Review
CVS Health, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health saw sales climb by double digits for the 2015 fourth quarter and fiscal year, fueled in large part by its acquisition of long-term care pharmacy provider Omnicare Inc., while adjusted earnings per share were in line with Wall Street’s forecast. CVS said Tuesday that revenue for the fourth quarter ended
February 3, 2016 by Chain Drug Review
Brian Cornell, CVS Health, CVS Pharmacy, Helena Foulkes, John Mulligan, Larry Merlo, MinuteClinic, Target Corp., video
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos
WOONSOCKET, R.I., and MINNEAPOLIS — The first CVS pharmacies have opened in six Target discount stores in North Carolina. Branded as CVS Pharmacy, the pharmacies are being operated as store-within-a-store departments and are located in Hickory, Monroe, Morrisville, Raleigh, Matthews and Wesley Chapel, N.C. Executives from CVS Health and Target Corp. — including CVS Pharmacy
January 4, 2016 by Geoff Walden and Chain Drug Review
Alex Gourlay, CVS Health, J. Michael Pearson, Larry Merlo, Valeant Pharmaceuticals International, Walgreens
2016, Issue 01-04-2016, Issues, News
DEERFIELD, Ill. — Walgreens and Valeant Pharmaceuticals International Inc. have inked a distribution deal that will cut prices of Valeant prescription products at Walgreens by 10%, and may be extended to independent retail pharmacies. The discount will apply to wholesale list prices and will be phased in over the next six to nine months. The
January 4, 2016 by Geoff Walden and Chain Drug Review
Brian Cornell, CVS Health, Larry Merlo, Target Corp.
2016, Issue 01-04-2016, Issues, News
WOONSOCKET, R.I. — CVS Health Corp. has completed the acquisition of Target Corp.’s pharmacy and clinic businesses, making CVS the No. 1 drug chain by store count and sales. With the closing of the $1.9 billion deal, CVS has picked up Target’s 1,672 pharmacies across 47 states, giving it more than 9,500 prescription counters. Walgreens
January 4, 2016 by Geoff Walden and Chain Drug Review
Analyst Day, Cardinal Health, CVS Health, David Denton, Larry Merlo, Omnicare, Red Oak Sourcing, Target Corp.
2016, Business, Issue 01-04-2016, Issues, News
NEW YORK — CVS Health has raised the midpoint of its earnings outlook for 2016 and reiterated its five-year steady state targets. The company now expects next year’s adjusted earnings per share to range from $5.73 to $5.88, reflecting solid year-over-year growth of 11.25% to 14.25%. The bottom end of the range was increased by
December 16, 2015 by Chain Drug Review
Brian Cornell, CVS Health, Larry Merlo, MinuteClinic, Target Corp.
Business, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I., and MINNEAPOLIS — CVS Health has completed its $1.9 billion acquisition of Target Corp.’s pharmacy and retail health clinic business. The companies said Wednesday that Target’s 1,672 pharmacies in 47 states will be branded as CVS/pharmacy and operated under a store-within-a-store format. A CVS/pharmacy will be in all new Target stores that offer
December 16, 2015 by John Schultz and Chain Drug Review
CVS Health, CVS/pharmacy, Larry Merlo, Omnicare, Red Oak Sourcing, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — At its annual Analyst Day event here, CVS Health updated its earnings guidance for 2016 and reiterated its five-year targets. “Over the past several years, CVS Health has been preparing for the changes in the health care landscape by expanding our extensive suite of leading assets and capabilities,” said president and chief
December 7, 2015 by David Pinto and Chain Drug Review
chain drug retailing, CVS, David Pinto, Helena Foulkes, John Standley, Larry Merlo, NACDS, National Association of Chain Drug Stores, Rite Aid, Walgreens
2015, Issue 12-07-2015, Issues, Opinion
The National Association of Chain Drug Stores held its year-end meetings in New York City early this month — and very little was as it had been a year ago. Many of the same familiar faces were on hand, and several of the same retail companies attended. But the yearlong series of events that have
December 3, 2015 by Chain Drug Review
Brian Cornell, CVS Health, David Denton, food/drug retailing, Institutional Investor, Larry Merlo, Target Corp.
CDR Blog
Larry Merlo, president and chief executive officer of CVS Health, was named the No. 1 CEO in the food/drug retailing sector by Institutional Investor magazine. Merlo was part of the financial publication’s “2016 All-America Executive Team,” in which more than 2,000 portfolio managers and analysts were asked to name the best CEOs, CFOs and investor
October 30, 2015 by Chain Drug Review
CVS Health, CVS/pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health posted sales gains in both its retail pharmacy and pharmacy services businesses for the 2015 third quarter, with adjusted earnings per share (EPS) finishing in line with analysts’ projections. CVS also said Friday that it has expanded its business segments to incorporate operations from the Omnicare Inc. acquisition, which closed
October 12, 2015 by David Pinto and Chain Drug Review
Alex Gourlay, chain drug retailing, CVS Health, David Pinto, Helena Foulkes, John Standley, Ken Martindale, Larry Merlo, Ornella Barra, Rite Aid, Walgreens, Walgreens Boots Alliance
2015, Issue 10-12-2015, Issues, Opinion
As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in
August 4, 2015 by Chain Drug Review
CVS Health, Larry Merlo, Omnicare, pharmacy sales, second quarter, Target pharmacy acquisition
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health saw sales climb in the second quarter and posted adjusted earnings per share in line with Wall Street’s forecast, despite the impact of costs from its pending Omnicare and Target pharmacy acquisitions. CVS said Tuesday that for the three months ended June 30, total sales rose 7.4% to $37.2 billion from